Targeting the DNA Repair Enzyme Polymerase θ in Cancer Therapy

被引：108
|
作者：
Schrempf, Anna [1 ,2 ]
Slyskova, Jana [1 ,2 ]
Loizou, Joanna, I [1 ,2 ]
机构：
[1] Austrian Acad Sci, CeMM Res Ctr Mol Med, Lazarettgasse 14,AKH BT 25-3, A-1090 Vienna, Austria
[2] Med Univ Vienna, Comprehens Canc Ctr, Inst Canc Res, Dept Med 1, A-1090 Vienna, Austria
来源：
TRENDS IN CANCER | 2021年 / 7卷 / 02期
基金：
欧洲研究理事会;
关键词：
DOUBLE-STRAND BREAKS; BASE EXCISION-REPAIR; HOMOLOGOUS-RECOMBINATION; POL-THETA; LIGASE-III; HELICASE DOMAIN; CELLS; RESISTANCE; TUMORS; BYPASS;
D O I：
10.1016/j.trecan.2020.09.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Targeted cancer therapies represent a milestone towards personalized treatment as they function via inhibition of cancer-specific alterations. Polymerase theta (POLQ), an error-prone translesion polymerase, also involved in DNA double-strand break (DSB) repair, is often upregulated in cancer. POLQ is synthetic lethal with various DNA repair genes, including known cancer drivers such as BRCA1/2, making it essential in homologous recombination-deficient cancers. Thus, POLQ represents a promising target in cancer therapy and efforts for the development of POLQ inhibitors are actively underway with first clinical trials due to start in 2021. This review summarizes the journey of POLQ from a backup DNA repair enzyme to a promising therapeutic target for cancer treatment.
引用
收藏
页码：98 / 111
页数：14
相关论文
共 50 条
  • [41] DNA polymerase ζ in DNA replication and repair
    Martin, Sara K.
    Wood, Richard D.
    NUCLEIC ACIDS RESEARCH, 2019, 47 (16) : 8348 - 8361
  • [42] Targeting DNA Damage Repair Mechanisms in Pancreas Cancer
    Perkhofer, Lukas
    Golan, Talia
    Cuyle, Pieter-Jan
    Matysiak-Budnik, Tamara
    Van Laethem, Jean-Luc
    Macarulla, Teresa
    Cauchin, Estelle
    Kleger, Alexander
    Beutel, Alica K.
    Gout, Johann
    Stenzinger, Albrecht
    Van Cutsem, Eric
    Bellmunt, Joaquim
    Hammel, Pascal
    O'Reilly, Eileen M.
    Seufferlein, Thomas
    CANCERS, 2021, 13 (17)
  • [43] Targeting checkpoint signaling and DNA repair in ovarian cancer
    Karnitz, Larry M.
    CLINICAL CANCER RESEARCH, 2016, 22
  • [44] Targeting DNA damage repair pathways in pancreas cancer
    Crowley, Fionnuala
    Park, Wungki
    O'Reilly, Eileen M.
    CANCER AND METASTASIS REVIEWS, 2021, 40 (03) : 891 - 908
  • [45] Targeting DNA Repair in Cancer : Beyond PARP Inhibitors
    Brown, Jessica S.
    O'Carrigan, Brent
    Jackson, Stephen P.
    Yap, Timothy A.
    CANCER DISCOVERY, 2017, 7 (01) : 20 - 37
  • [46] Targeting DNA damage repair pathways in pancreas cancer
    Fionnuala Crowley
    Wungki Park
    Eileen M. O’Reilly
    Cancer and Metastasis Reviews, 2021, 40 : 891 - 908
  • [47] Targeting deficient DNA damage repair in gastric cancer
    Young, Kate
    Starling, Naureen
    Cunningham, David
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (13) : 1757 - 1766
  • [48] Targeting DNA repair pathways for new cancer treatment
    Miki, Yoshio
    Sunada, Shigeaki
    Nakanishi, Akira
    CANCER SCIENCE, 2021, 112 : 157 - 157
  • [49] Editorial: Cancer Therapeutics: Targeting DNA Repair Pathways
    Suraweera, Amila
    Brown, James A. L.
    Lim, Yi Chieh
    Lavin, Martin F.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [50] Targeting DNA Repair in Ovarian Cancer Treatment Resistance
    Wong-Brown, M. W.
    van der Westhuizen, A.
    Bowden, N. A.
    CLINICAL ONCOLOGY, 2020, 32 (08) : 518 - 526
12345